HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer. Zhou Y, Jin X, Ma J, Ding D, et al. Cancer Res 2021;81:1486-1499.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou Y, Jin X, Ma J, Ding D, et al. HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer. Cancer Res 2021;81:1486-1499.
PMID: 33419772